Get started
MediPharm Labs Corp.MediPharm Labs Corp.MediPharm Labs Corp.

MediPharm Labs Corp.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals

Financial actuals and estimates


Explore reported financial data and analyst estimates across the income statement, balance sheet, cash flow statement, and valuation metrics. Compare actual results with average, high, and low estimates, and visualize trends over time.
Income statementBalance sheetCash flow
Disclaimer
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.

Frequently asked questions


The current price of LABS is 0.075 CAD — it has decreased by −6.25% in the past 24 hours. Watch MediPharm Labs Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange MediPharm Labs Corp. stocks are traded under the ticker LABS.
LABS stock has fallen by −16.67% compared to the previous week, the month change is a 7.14% rise, over the last year MediPharm Labs Corp. has showed a 7.14% increase.
LABS reached its all-time high on May 14, 2019 with the price of 7.390 CAD, and its all-time low was 0.055 CAD and was reached on Jun 27, 2023. View more price dynamics on LABS chart.
See other stocks reaching their highest and lowest prices.
LABS stock is 6.67% volatile and has beta coefficient of 0.67. Track MediPharm Labs Corp. stock price on the chart and check out the list of the most volatile stocks — is MediPharm Labs Corp. there?
Today MediPharm Labs Corp. has the market capitalization of ‪31.86 M‬, it has increased by 4.00% over the last week.
Yes, you can track MediPharm Labs Corp. financials in yearly and quarterly reports right on TradingView.
MediPharm Labs Corp. is going to release the next earnings report on Aug 17, 2026. Keep track of upcoming events with our Earnings Calendar.
MediPharm Labs Corp. revenue for the last quarter amounts to ‪8.96 M‬ CAD, despite the estimated figure of ‪8.70 M‬ CAD. In the next quarter, revenue is expected to reach ‪8.93 M‬ CAD.
LABS net income for the last quarter is ‪−867.00 K‬ CAD, while the quarter before that showed ‪−1.97 M‬ CAD of net income which accounts for 0.00% change. Track more MediPharm Labs Corp. financial stats to get the full picture.
No, LABS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 27, 2026, the company has 127 employees. See our rating of the largest employees — is MediPharm Labs Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MediPharm Labs Corp. EBITDA is ‪−7.20 M‬ CAD, and current EBITDA margin is −15.48%. See more stats in MediPharm Labs Corp. financial statements.
Like other stocks, LABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MediPharm Labs Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MediPharm Labs Corp. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MediPharm Labs Corp. stock shows the neutral signal. See more of MediPharm Labs Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.